Open AccessEmergence of institutional antithrombotic protocols for coronavirus 2019
Author(s) -
Cohoon Kevin P.,
Mahé Guillaume,
Tafur Alfonso J.,
Spyropoulos Alex C.
Publication year - 2020
Publication title -
research and practice in thrombosis and haemostasis
Language(s) - English
Resource type - Journals
ISSN - 2475-0379
DOI - 10.1002/rth2.12358
Subject(s) - coronavirus , medicine , coagulopathy , outbreak , covid-19 , pandemic , virology , disease , infectious disease (medical specialty) , intensive care medicine
The coronavirus infection (COVID-19), first identified in December 2019 in Wuhan, China, is a major public health crisis with new infections increasing exponentially worldwide. COVID-19 is an acute infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and has contributed to significant morbidity and mortality, including the development of coagulopathy. Similar thrombotic and thromboembolic events have occurred during other viral outbreaks, including severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome (MERS-CoV), and influenza A H1N1.